More powerful than previous analogues, Retratutide represents a revolution in weight control and metabolic modulation.
Nuvilab introduces Retratutide, a next-generation peptide that combines multiple hormonal pathways into a single molecule.
Inspired by the clinical success of Tirzepatide, Retratutide goes even further — acting on GIP, GLP-1 and glucagon receptors, enhancing fat oxidation, appetite regulation, and metabolic acceleration.
International studies show over 25% total body weight reduction within 48 weeks, along with improved insulin sensitivity and glycemic control.
With scientific rigor and pharmaceutical purity, Nuvilab’s Retratutide brings a new era of performance-based metabolic science.
Signature:
Nuvilab — innovation that redefines human metabolism.
